Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://www.sentinelinitiative.org/studies/drugs/provigil-modafinil-and-nuvigil-armodafinil-0 Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac Malformations Studies 11/17/2020
Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac Malformations
Studies 11/17/2020
https://www.sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools 02/24/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/adbry-tralokinumab Assessment of ARIA Sufficiency: Adbry (tralokinumab) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Adbry (tralokinumab)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/bylvay-odevixibat Assessment of ARIA Sufficiency: Bylvay (odevixibat) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Bylvay (odevixibat)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/camzyos-mavacamten Assessment of ARIA Sufficiency: Camzyos (mavacamten) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Camzyos (mavacamten)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/enjaymo-sutimlimab-jome Assessment of ARIA Sufficiency: Enjaymo (sutimlimab-jome) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Enjaymo (sutimlimab-jome)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/nextstellis-drospirenone-and-estetrol Assessment of ARIA Sufficiency: Nextstellis (drospirenone and estetrol) Assessments 04/08/2021
Assessment of ARIA Sufficiency: Nextstellis (drospirenone and estetrol)
Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/quviviq-daridorexant Assessment of ARIA Sufficiency: Quviviq (daridorexant) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Quviviq (daridorexant)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/reyvow-lasmiditan Assessment of ARIA Sufficiency: Reyvow (lasmiditan) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Reyvow (lasmiditan)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/voquezna-dual-pak Assessment of ARIA Sufficiency: Voquezna Dual Pak (vonoprazan/amoxicillin) Sufficiency Assessments 04/08/2021
Assessment of ARIA Sufficiency: Voquezna Dual Pak (vonoprazan/amoxicillin)
Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-heart Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis Modular Programs 04/21/2021
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis
Modular Programs 04/21/2021
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/angioedema-and-serious-angioedema-algorithms-defined Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis" Methods, Data, & Tools 04/21/2021
Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis"
Methods, Data, & Tools 04/21/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools 05/17/2021
Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)
Methods, Data, & Tools 05/17/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/longitudinal-trends-incident-and-prevalent-use-long-acting-beta-2 Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis Methods, Data, & Tools 08/24/2021
Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis
Methods, Data, & Tools 08/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/new-analytic-tool-interrupted-times-series-analysis-assess A New Analytic Tool for Interrupted Times Series Analysis to Assess the Impact of FDA Regulatory Actions Publications and Presentations 08/24/2021
A New Analytic Tool for Interrupted Times Series Analysis to Assess the Impact of FDA Regulatory Actions
Publications and Presentations 08/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/improving-methods-identifying-anaphylaxis-medical-product Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning Publications and Presentations 08/25/2021
Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning
Publications and Presentations 08/25/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/ubrelvy-ubrogepant Assessment of ARIA Sufficiency: Ubrelvy (ubrogepant) Sufficiency Assessments 08/27/2021
Assessment of ARIA Sufficiency: Ubrelvy (ubrogepant)
Sufficiency Assessments 08/27/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/natural-history-coagulopathy-covid-19-0 Natural History of Coagulopathy in COVID-19 Publications and Presentations 10/06/2021
Natural History of Coagulopathy in COVID-19
Publications and Presentations 10/06/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center 2022 Sentinel Community Building and Outreach Center Webinar Series Sentinel Initiative Events 11/23/2021
2022 Sentinel Community Building and Outreach Center Webinar Series
Sentinel Initiative Events 11/23/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series 2022 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2022
2022 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events 01/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/mometasone-furoate-sinus-implant-use-patients-nasal-polyps Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis Analyses 03/03/2022
Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis
Analyses 03/03/2022
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter Quarterly Newsletter Spotlight 03/24/2022
Quarterly Newsletter
Spotlight 03/24/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools 06/01/2022
Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes
Methods, Data, & Tools 06/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-sodium-glucose-co-transporter-2-sglt-2-inhibitor Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis Analyses 07/11/2022
Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis
Analyses 07/11/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-obesity-drugs-descriptive-analysis Utilization of Obesity Drugs: A Descriptive Analysis Analyses 08/05/2022
Utilization of Obesity Drugs: A Descriptive Analysis
Analyses 08/05/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/association-covid-19-vs-influenza-risk-arterial-and-venous Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients Publications and Presentations 08/16/2022
Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients
Publications and Presentations 08/16/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations 08/26/2022
Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
Publications and Presentations 08/26/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/racial-differences-us-covid-19-positivity-hospitalization Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality Spotlight 08/28/2022
Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality
Spotlight 08/28/2022
https://www.sentinelinitiative.org/methods-data-tools/sentinel-national-resource/patient-characteristics-pain-treatment-patterns-and Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a US Population With Osteoarthritis 09/23/2022
Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a US Population With Osteoarthritis
09/23/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/association-covid-19-vs-influenza-risk-arterial-and-venous-0 Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients Publications and Presentations 10/20/2022
Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients
Publications and Presentations 10/20/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/spironolactone-utilization-among-patients-reduced-and Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure Publications and Presentations 10/20/2022
Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure
Publications and Presentations 10/20/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners Onboarding of Commercial Electronic Health Record (EHR) Data Partners Methods, Data, & Tools 11/01/2022
Onboarding of Commercial Electronic Health Record (EHR) Data Partners
Methods, Data, & Tools 11/01/2022
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format Methods, Data, & Tools 11/01/2022
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools 11/01/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/new-analytic-tool-assessing-impact-us-food-and-drug A New Analytic Tool for Assessing the Impact of the US Food and Drug Administration Regulatory Actions Publications and Presentations 11/04/2022
A New Analytic Tool for Assessing the Impact of the US Food and Drug Administration Regulatory Actions
Publications and Presentations 11/04/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/improving-methods-identifying-anaphylaxis-medical-product-0 Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning Publications and Presentations 11/04/2022
Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning
Publications and Presentations 11/04/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/data-driven-automated-classification-algorithms-acute-health Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to COVID 19 Disease Publications and Presentations 11/07/2022
Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to COVID 19 Disease
Publications and Presentations 11/07/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/assessing-medical-product-safety-during-pregnancy-using Assessing Medical Product Safety During Pregnancy using Parameterizable Tools in the Sentinel Distributed Database Publications and Presentations 11/09/2022
Assessing Medical Product Safety During Pregnancy using Parameterizable Tools in the Sentinel Distributed Database
Publications and Presentations 11/09/2022
https://www.sentinelinitiative.org/studies/drugs/ozempic-semaglutide Ozempic (Semaglutide) & Signal Identification Studies 11/10/2022
Ozempic (Semaglutide) & Signal Identification
Studies 11/10/2022
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz Zarxio (Filgrastim-sndz) & Signal Identification Studies 11/10/2022
Zarxio (Filgrastim-sndz) & Signal Identification
Studies 11/10/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-signal Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis Analyses 11/10/2022
Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis
Analyses 11/10/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2 Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses 11/10/2022
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Analyses 11/10/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ixekizumab-pregnant-patients-descriptive Utilization of Ixekizumab in Pregnant Patients: A Descriptive Analysis Analyses 11/14/2022
Utilization of Ixekizumab in Pregnant Patients: A Descriptive Analysis
Analyses 11/14/2022
https://www.sentinelinitiative.org/studies/drugs/taltz-ixekizumab Taltz (Ixekizumab) & Use in Pregnancy Studies 11/14/2022
Taltz (Ixekizumab) & Use in Pregnancy
Studies 11/14/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-14th-annual-sentinel-public-workshop 2022 14th Annual Sentinel Public Workshop Sentinel Initiative Events 11/15/2022
2022 14th Annual Sentinel Public Workshop
Sentinel Initiative Events 11/15/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/scalable-phenotyping-safety-outcomes-using-electronic-health Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data Publications and Presentations 11/17/2022
Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data
Publications and Presentations 11/17/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/using-food-and-drug-administrations-sentinel-system Using the Food and Drug Administration's Sentinel System for Surveillance of TB Infection Publications and Presentations 12/01/2022
Using the Food and Drug Administration's Sentinel System for Surveillance of TB Infection
Publications and Presentations 12/01/2022
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/wegovy-semaglutide Assessment of ARIA Sufficiency: Wegovy (semaglutide) Sufficiency Assessments 12/07/2022
Assessment of ARIA Sufficiency: Wegovy (semaglutide)
Sufficiency Assessments 12/07/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools 12/09/2022
Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment
Methods, Data, & Tools 12/09/2022
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/empaveli-pegcetacoplan Assessment of ARIA Sufficiency: Empaveli (pegcetacoplan) Sufficiency Assessments 12/12/2022
Assessment of ARIA Sufficiency: Empaveli (pegcetacoplan)
Sufficiency Assessments 12/12/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/monitoring-safety-and-effectiveness-covid-19-therapeutics-aim-1-protocol Monitoring of Safety and Effectiveness of COVID-19 Therapeutics: Aim 1 Protocol Development Study Protocols & Surveillance Plan 12/13/2022
Monitoring of Safety and Effectiveness of COVID-19 Therapeutics: Aim 1 Protocol Development
Study Protocols & Surveillance Plan 12/13/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/machine-learning-distributed-data-networks-fda-sentinel Machine Learning in Distributed Data Networks like the FDA Sentinel System: Opportunities, Challenges, and Considerations Sentinel Initiative Events 12/16/2022
Machine Learning in Distributed Data Networks like the FDA Sentinel System: Opportunities, Challenges, and Considerations
Sentinel Initiative Events 12/16/2022
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/nexviazyme-avalglucosidase-alfa Assessment of ARIA Sufficiency: Nexviazyme (avalglucosidase alfa) Sufficiency Assessments 12/27/2022
Assessment of ARIA Sufficiency: Nexviazyme (avalglucosidase alfa)
Sufficiency Assessments 12/27/2022
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/pradaxa-dabigatran-etexilate Assessment of ARIA Sufficiency: Pradaxa (dabigatran etexilate) Sufficiency Assessments 12/27/2022
Assessment of ARIA Sufficiency: Pradaxa (dabigatran etexilate)
Sufficiency Assessments 12/27/2022
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/cibinqo-abrocitinib Assessment of ARIA Sufficiency: Cibinqo (abrocitinib) Sufficiency Assessments 12/29/2022
Assessment of ARIA Sufficiency: Cibinqo (abrocitinib)
Sufficiency Assessments 12/29/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-innovation-and-methods-seminar-series 2023 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2023
2023 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events 01/01/2023
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools 01/06/2023
Sentinel Routine Querying System
Methods, Data, & Tools 01/06/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/exploring-claims-based-definitions-and-characterizing Exploring Claims-Based Definitions of, and Characterizing Patients with, Respiratory Failure: A Descriptive Analysis Analyses 01/10/2023
Exploring Claims-Based Definitions of, and Characterizing Patients with, Respiratory Failure: A Descriptive Analysis
Analyses 01/10/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/identifying-potential-risk-factors-respiratory-failure Identifying Potential Risk Factors for Respiratory Failure: A Descriptive Analysis Analyses 01/10/2023
Identifying Potential Risk Factors for Respiratory Failure: A Descriptive Analysis
Analyses 01/10/2023
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/amvuttra-vutrisiran Assessment of ARIA Sufficiency: Amvuttra (vutrisiran) Sufficiency Assessments 01/11/2023
Assessment of ARIA Sufficiency: Amvuttra (vutrisiran)
Sufficiency Assessments 01/11/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-patients-and-encounters-trinetx-live-usa Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis Analyses 01/12/2023
Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis
Analyses 01/12/2023
https://www.sentinelinitiative.org/studies/drugs/olumiant-baricitinib Olumiant (Baricitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke Studies 01/17/2023
Olumiant (Baricitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke
Studies 01/17/2023
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/voquezna-triple-pak Assessment of ARIA Sufficiency: Voquezna Triple Pak (vonoprazan/amoxicillin/clarithromycin) Sufficiency Assessments 01/19/2023
Assessment of ARIA Sufficiency: Voquezna Triple Pak (vonoprazan/amoxicillin/clarithromycin)
Sufficiency Assessments 01/19/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/identification-and-mitigation-source-mapping-issues Identification and Mitigation of Source Mapping Issues in Structured Electronic Health Record Data Sentinel Initiative Events 01/23/2023
Identification and Mitigation of Source Mapping Issues in Structured Electronic Health Record Data
Sentinel Initiative Events 01/23/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/comparative-risk-angioedema-sacubitril-valsartan-versus Comparative Risk of Angioedema with Sacubitril-Valsartan Versus Renin-Angiotensin-Aldosterone Inhibitors Publications and Presentations 01/24/2023
Comparative Risk of Angioedema with Sacubitril-Valsartan Versus Renin-Angiotensin-Aldosterone Inhibitors
Publications and Presentations 01/24/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/ontology-driven-weak-supervision-clinical-entity Ontology-Driven Weak Supervision for Clinical Entity Classification in Electronic Health Records Sentinel Initiative Events 02/28/2023
Ontology-Driven Weak Supervision for Clinical Entity Classification in Electronic Health Records
Sentinel Initiative Events 02/28/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-public-training-innovation-day-april-11-12 2023 Sentinel Public Training & Innovation Day, April 11-12 Sentinel Initiative Events 04/11/2023
2023 Sentinel Public Training & Innovation Day, April 11-12
Sentinel Initiative Events 04/11/2023